Search the Community
Showing results for tags 'Dr. Donald Abrams'.
Found 2 results
Any thoughts or predictions on this (Gambling is illegal at Bushwood and Sir, I never slice). 1. Who wins this one? A. Science 2. If rescheduling to what number? A. 2 (should be a 4) 3. If rescheduling occurs is this good or bad for the Michigan Patient Community? A. Good, in short term, uncertainty after that. http://www.enewspf.c...y-20-years.html Audiotape of yesterday's teleconference briefing with researchers, legal counsel and lawsuit plaintiff now available WASHINGTON--(ENEWSPF)--October 5 - For the first time in nearly 20 years, a United States Court of Appeals is set to hear oral arguments in a lawsuit challenging the federal government's classification of marijuana as a dangerous drug with no medicinal value: Americans for Safe Access v. Drug Enforcement Administration. This historic case will force a federal court to finally review the scientific evidence regarding the therapeutic efficacy of marijuana. During a press briefing Thursday, plaintiffs in the case, along with leading medical researchers and clinicians, spoke about the necessity of the federal government recognizing current scientific data supporting marijuana rescheduling. Marijuana is currently classified in the same category as heroin despite calls from scientists, medical professionals, and policy makers to reschedule marijuana for medical use. The U.S. Court of Appeals for the D.C. Circuit will hear opening arguments on the case the morning of October 16, 2012. "Medical marijuana patients are finally getting their day in court," said Joe Elford, Chief Counsel with Americans for Safe Access (ASA), who will be arguing the case before the D.C. Circuit. "What's at stake in this case is nothing less than our country's scientific integrity and the imminent needs of millions of patients." On the call, Dr. Donald Abrams, Director of Clinical Programs at San Francisco General Hospital, described the effectiveness of medical marijuana in the treatment regimens of cancer and HIV/AIDS patients. "In my practice every day as a cancer specialist I see patients who have loss of appetite, nausea and vomiting from their chemotherapy, pain on and off of opiates, anxiety, depression, and insomnia," conditions which Dr. Abrams said can be alleviated by medical marijuana. Dr. Igor Grant, Executive Vice-Chair, Department of Psychiatry, University of California-San Diego School of Medicine, and director of the Center for Medicinal Cannabis Research, stated that multiple California state-supported studies have resulted in "very good evidence" that medical marijuana "is effective in treating muscle spasticity," which is often experienced by patients with Multiple sclerosis and other painful disorders. He added that it is critical to separate out patients' legitimate medical needs from other issues surrounding marijuana's distribution and usage. Dr. Grant recently published a study in Open Neurology Journal concluding that marijuana's current classification is "untenable." Plaintiff Michael Krawitz, a Gulf War veteran and medical marijuana patient, conveyed his struggle in managing his combat-related pain without relinquishing federally-mandated VA benefits under marijuana's current classification. Without access to medical marijuana, he stated he is in danger of destabilizing his overall health condition, a situation Krawitz has faced multiple times due to federal policy. Steph Sherer, ASA’s Executive Director, ended the call by noting that the rescheduling case coincides with the organization's 10th anniversary of its founding, which will be marked by an event the night of October 16th honoring individuals, including numerous elected officials, who have led the fight for patient access. "The time has come to address medical marijuana as a public health issue and for the federal government to prioritize science over politics," Sherer said. Further information: Audio recording of Thursday's teleconference briefing on the rescheduling case: http://snd.sc/OHKSoR Details of ASA's 10th anniversary dinner on October 16th: http://AmericansForS...rg/oct16-dinner Michael A. Komorn Attorney and Counselor Law Office of Michael A. Komorn 3000 Town Center, Suite, 1800 Southfield, MI 48075 800-656-3557 (Toll Free) 248-351-2200 (Office) 248-357-2550 (Phone) 248-351-2211 (Fax) Email: firstname.lastname@example.org Website: www.komornlaw.com Check out our Radio show: http://www.blogtalkr...lanetgreentrees CALL IN NUMBER: (347) 326-9626 Live Every Thursday 8-10:00p.m. PLANET GREENTREES w/ Attorney Michael Komorn The most relevant radio talk show for the Michigan Medical Marijuana Community. PERIOD.
Findings inspire medical pot researcher Victoria Colliver Published 5:27 p.m., Tuesday, September 18, 2012 http://www.sfgate.com/health/article/Findings-inspire-medical-pot-researcher-3875582.php The therapeutic uses of cannabis have long been a focus of research for Dr. Donald Abrams, UCSF professor and chief of the hematology-oncology division at San Francisco General Hospital. Abrams wrote a study last year on the combination of cannabinoids - the main ingredient in cannabis or medical marijuana - and pain drugs. Abrams talks about the preclinical work by the California Pacific Medical Center Research Institute and other research on cancer and cannabis, 16 years after California became the first state to legalize medical marijuana. Q: Is it difficult, due to stigma or the political climate, to do research on the therapeutic benefits of cannabis? A: The only way you can get cannabis to do research in this county is through the National Institute on Drug Abuse, or NIDA, and it's clear the congressional mandate is to study the substance for abuse rather than for treatment. It started in 1997 in HIV research when we studied whether it was safe to inhale cannabis while on protease inhibitors. The next study was through the UC Center for Medicinal Cannabis Research in 1999, when the state budget surplus allowed the state to devote $3 million for three years of studies to demonstrate whether cannabis had medical use. The funding enabled a number of studies and NIDA supplied the cannabis, but that money ran out. If this plant were discovered in the Amazon today, scientists would be falling all over each other to be the first to bring it to market. But it has a stigma, and it's being attacked by our government as part of the war on drugs. Q: What kind of research are you doing now? A: We did a study in patients with HIV who had damage to their nerves. We showed inhaling cannabis was better than inhaling a cannabis placebo for relieving those symptoms and that vaporization of cannabis was equivalent to smoking. The last study we did, which was again funded by NIDA, was looking to see if it was safe to combine cannabis with opiates - sustained-release morphine and sustained-release oxycodone. It was a small study ... but we did note patients had increased relief of pain when cannabinoids were added to the opiates. Q: What do you think of the research being done on triple-negative breast cancer cells at the California Pacific Medical Center Research Institute? A: The data is promising and it's elegant, but the true test is now really going to be to do some clinical trials in the patient population that (the researchers) think is correct to study at this time, which is patients with triple negative breast cancer. But at this time I would not tell my triple-negative patients to go out and look at taking high cannabidiol-containing cannabis products. We need to do the research. What happens in the test tube or even in animal models does not necessarily predict what happens in people. People are much more complex. Q: What do you think about the University of Southern California study released last week that found a link between the recreational use of marijuana among young men and testicular cancer? A: Young men use cannabis and get cancer. If they looked at video games and riding bicycles, that might also be associated. Is there an epidemic of testicular cancer in Jamaica where Rastafarians use cannabis religiously? I think that's all a trick of numbers, personally. Michael A. Komorn Attorney and Counselor Law Office of Michael A. Komorn 3000 Town Center, Suite, 1800 Southfield, MI 48075 800-656-3557 (Toll Free) 248-351-2200 (Office) 248-357-2550 (Phone) 248-351-2211 (Fax) Email: email@example.com Website: www.komornlaw.com Check out our Radio show: http://www.blogtalkradio.com/planetgreentrees CALL IN NUMBER: (347) 326-9626 Live Every Thursday 8-10:00p.m. PLANET GREENTREES w/ Attorney Michael Komorn The most relevant radio talk show for the Michigan Medical Marijuana Community. PERIOD.